Browse > Article

Purification of Recombinant CTP-Conjugated Human prostatic acid phosphatase for activation of Dendritic Cell  

Yi, Ki-Wan (Protein Engineering Team, CreaGene Inc.)
Ryu, Kang (Protein Engineering Team, CreaGene Inc.)
Publication Information
KSBB Journal / v.24, no.1, 2009 , pp. 80-88 More about this Journal
Abstract
Human prostatic acid phosphatase (PAP), with comprehensive homology to glandular kallikrein, are representative serum biomarkers of prostate cancer. Dendritic cell (DC), which is the potent antigen-presenting cells(APC) in the immune system, can induce strong T cell responses against viruses, microbial pathogens, and tumors. Therefore, the immunization using DC loaded with tumor-associated antigens is a powerful method for inducing anti-tumor immunity. The CTP (Cytoplasmic Transduction Peptide) technology developed by Creagene which can transport attached bio-polymers like nucleic acids or proteins into the cell with high permeation efficiency. As the active forms of PAP can mediate apoptotic processing, we used multimer forms of PAP as an inactive form for antigen pulsing of DCs. In this study, multimeric forms of CTP-rhPAP was obtained according to the advanced purification process and subsequently confirmed by gel filtration chromatography, western blot and Dynamic Light Scattering. Therefore, CTP-conjugated PA multimers transduced into the cytoplasm were efficiently presented on the cell surface without any harm effect on cells via MHC class I molecules and result in induction of a large number of effector cell.
Keywords
Human prostatic acid phosphatase; Dendritic cell; antigen; Cytoplasmic Transduction Peptide; multimer; nanoparticle;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Young-Woock Noh and Jong-Seok Lim (2006), Effect of Lipofectin on Antigen-presenting Function and Anti-tumor Activity of Dendritic Cells, lmmune Network, 6(2), 102-110   DOI
2 Nouri-Shirazi M, Banchereau J, Fay J, and Palucka K (2000), Dendritic cell based tumor vaccines. lmmunol Lefter 74, 5-10
3 Steven P. Balk, Yoo-Joung Ko, and Glenn J. Bubley (2003), Biology of Prostate-Specific Antigεn. J Clin Oncol 21(2), 383-391   DOI   ScienceOn
4 Apostol I, Kuciel R, Wasylewska E & Ostrowski WS (1985), Phosphotyrosine as a substrate of acid and alkaline phosphatases. Acta Biochem Pol 32, 187-197
5 Chemoff J (1999), Protein tyrosine phosphatases as negative regulators of mitogenic signaling. J Cell Physiol 180, 173-181   DOI   PUBMED   ScienceOn
6 Woodford-Thomas T A, Rhodes JD & Dixon JE (1992), Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts. J Cell Biol 117, 401-414   DOI   ScienceOn
7 Tonks NK & Nee1 BG (1996), From form to function: signaling by protein tyrosine phosphatases. Cell. 87, 365-368   DOI   ScienceOn
8 Lin MF, Meng TC, Rao PS Chang C, Schonthal AH & Lin FF (1998), Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines. J Biol Chem 273, 5939-5947   DOI   ScienceOn
9 Vania Manolova, Anna Flace, Monika Bauer, Katrin Schwarz, Philippe Saudan, and Martin F. Bachmarm (2008), Nanoparticles target distinct dendritic cell populations according to their size, European Journal ollmmunology, Vol. 38 Issue 5, Pages 1404-1413   DOI   ScienceOn
10 Luchter-Wasylewska E (2001), Cooperative kinetics of human prostatic acid phosphatase, Biochim Biophys Acta 1548, 257-264   DOI   PUBMED
11 Lin MF & Clinton GM (1988), The epidennal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase. Mol Cell Biol 8, 5477-5485   PUBMED   ScienceOn
12 Li L & Dixon JE (2000), Fonn, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin Immunol 12, 75-84   DOI   ScienceOn
13 Ronnberg L Vihko P, Sajanti E & Vihko R (1981), Clomiphene citrate administration to nonnogonadotropic subfertile men: Blood honnone changes and activation of acid phosphatase in seminal fluid. Int J Androl 4, 372-378   DOI   PUBMED
14 Hakalahti L, Vihko P, Henttu P, Autio-Hannainen H, Soini Y & Vihko R (1993), Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using Northem blot analysis, in situ hybridization and immunochemical stainings with monoclonal and bispecific antibodies. lnt J Cancer 55, 590-597   DOI   ScienceOn
15 Li HC, Chemoff J Chen LB & Kirschonbaum A (1984), A phosphotyrosyl-protein activity associated with acid phosphatase from human prostate gland. Eur J Biochem 138, 45-51   DOI   ScienceOn
16 Boissonneault M, Chapdelaine A & Chevalier S (1995), The enhancement by pervanadate of tyrosine phosphorylation on prostatic proteins occurs through the inhibition of membraneassociated tyrosine phosphatase. Mol Cell Biochem 153, 139-144   DOI   PUBMED
17 Wasylewska E, Czubak J & Ostrowski WS (1983), Phosphoprotεin phosphatase activity of human prostate acid phosphatase. Acta Biochim Pol 30, 175-184   PUBMED   ScienceOn
18 Ausubel, F. M., R Brent, R E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K Struhl (2002), Short Protocols in Molecular Biology : A Compendium of Methods from Current Protocols in Molecular Biology, 5th ed. John Wiley & Sons, Inc
19 한국인의 전립선암의 역학적 고찰, 한국비뇨기종양학회지 2004, 2(1), 27-30
20 Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, and Palucka K (2000), Immunobiology of dendritic cells. Annu Rev lmmunol 18, 767-811   DOI   ScienceOn
21 Daeyou Kima, Choonju Jeon, Jeong-Hwan Kim, Mi-Seon Kim, Cheol-Hee Yoon, In-Soo Choi, Sung-Hoon Kim, and Yong-Soo Bae (2006), Cytoplasmic transduction peptide (CTP): New approach for the delivery of biomolecules into cytoplasm in vitro and in vivo, Experimental Cell Research, Vol. 312, Issue 8, Pages 1277-1288   DOI   ScienceOn
22 Vihko P, Kurkela R, Porvari K, Herrala A, Lindfors A, Lindqvist Y & Schneider G (1993), Rat acid phosphatase: Overexpression of active secreted enzyme by recombinant baculovirus-infected insect cells, molecular properties and crystallization. Proc Natl Acad Sci USA 90, 799-803   DOI   ScienceOn
23 Small EJ and Voge1zang NJ (1997), Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm. Variety. J Clin Oncol, 15, 382-8   DOI
24 Hyunah Lee, Kwang-Min Choi, Soyoung Baek, Hong-Ghi Lee, and Chul-Won Jung (2004), Dendritic Cell Based Cancer Immunotherapy: in vivo Study with Mouse Renal Cell Carcinoma Model, lmmune Network, 4(1), 44-52   DOI
25 Lin MF & Clinton GM (1986), Human prostatic acid phosphatase has phosphotyrosyl-protein phosphatase activity. Biochem J 235, 351-357   PUBMED   ScienceOn
26 Whiteside TL and Odoux C (2004), Dendritic cell biology and cancer therapy. Cancer lmmunol lmmunother 53, 240-248   DOI   ScienceOn
27 Meng TC, Lee MS & Lin MF (2000), Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells. Oncogene 19, 2664-2677   DOI   ScienceOn
28 Hilkens CM, Kalinski P, de Boεr M, and Kapsenberg ML (1997), Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T -helper cells toward the Th1 phenotype. Blood 90, 1920-1926   PUBMED
29 Patricia L. Mottram, David Leong, Blessing CrimeenIrwin, Simone Gloster, Sue D. Xiang, Jayesh Meanger, Reena Ghildyal, Nicholas Vardaxis, and Magdalena P1ebanski (2007), Mol. Phannaceutics, 4(1), pp73-84   DOI   ScienceOn
30 전립선암의 역학과 자연사, 한국비뇨기종양학회지 2003, 1(1), 6-9
31 Lin MF & Meng TC (1996). Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp 185) inversely correlated with the cellular activity of human prostatic acid phosphatase. Biochem Biophys Res Comm 226, 206-213   DOI   ScienceOn
32 Tessier S, Chapdelaine A & Chevalier S (1987), Effect of vanadate on protein phosphorylation and on acid phosphatase activity in the canine prostate. Mol Cell Endocrinol 64, 87-94   DOI   ScienceOn
33 Li HC, Chernoff J Chen LB & Kirschonbaum A (1984), A phosphotyrosyl-protein activity associated with acid phosphatase from human prostate gland. Eur J Biochem 138, 45-51   DOI   ScienceOn
34 Banchereau J and Steinman RM (1998), Dendritic cells and the control of immunity. Nature 392, 245-252   DOI   ScienceOn
35 Steinman RM and Cohn ZA (1973), Identificaion of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137, 1142-1162   DOI   ScienceOn
36 A. R. O' Connell and C. Stenson-Cox (2007), A more serine way to die: Defining the characteristics of serine protease-mediated cell death cascade. Biochemica et Biophysica Acta 1773(10), 1491-1499   DOI